Harsh Shah

8PUBLICATIONS
36CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 19, 2024
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.

Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald

|Apr 20, 2023
Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia.

Victoria A Vardell, Daniel A Ermann, Lindsey A Fitzgerald

|Feb 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.

Julio C Chavez, Francine M Foss, Basem M William

|Jan 11, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.

Sanjal H Desai, Michael A Spinner, Kevin David

|Nov 21, 2022
Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era.

Jordan B Fenlon, Ryan J Hutten, Skyler B Johnson

|Nov 18, 2022
A comprehensive SEER registry analysis of elderly patients with classical Hodgkin lymphoma based on treatment era and race.

Harsh Shah, Hyejeong Jang, Seongho Kim

Pageof 2

Frequent Collaborators

2 joint publications

Victoria A Vardell

2 joint publications

Daniel A Ermann

2 joint publications

Boyu Hu

1 joint publications

Mark A Fiala